KRISTEN F SANDOZ
Allopathic & Osteopathic Physicians|Pediatrics LAFAYETTE, LA NPI 1992201628
Browse related groups: Allopathic & Osteopathic Physicians|Pediatrics LA SANOFI-AVENTIS U.S. LLC All categories
General Payments — all program years on this page
$390.03
- Category: General Payments
- Program years: PY2022–2024
- Record count: 23
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $127.78 across 7 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $127.78 | 7 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| SANOFI-AVENTIS U.S. LLC | $45.28 | 2 |
| Neos Therapeutics, LP | $31.43 | 2 |
| Ultragenyx Pharmaceutical Inc. | $18.84 | 1 |
| Acerta Pharma LLC | $17.87 | 1 |
| Merck Sharp & Dohme Corporation | $14.36 | 1 |
By program year
Records — PY2024 (7)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1082665379 | Neos Therapeutics, LP | $16.36 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1082671959 | Neos Therapeutics, LP | $15.07 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1104753608 | AstraZeneca Pharmaceuticals LP | $17.87 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1139940527 | SANOFI-AVENTIS U.S. LLC | $23.88 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1139940595 | SANOFI-AVENTIS U.S. LLC | $21.40 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1141868573 | Merck Sharp & Dohme LLC | $14.36 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1153285877 | Ultragenyx Pharmaceutical Inc. | $18.84 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.